CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
-4.88%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$93.3M
AUM Growth
+$93.3M
(+3.2%)
Cap. Flow
+$8.2M
Cap. Flow
% of AUM
8.79%
Top 10 Holdings %
Top 10 Hldgs %
92.33%
Holding
31
New
6
Increased
13
Reduced
5
Closed
2
Top Buys
| 1 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$4.35M |
| 2 |
MTEM
Molecular Templates, Inc.
MTEM
|
$2.94M |
| 3 |
SCYNEXIS
SCYX
|
$1.64M |
| 4 |
KALA BIO
KALA
|
$506K |
| 5 |
ARQL
Arqule Inc
ARQL
|
$438K |
Top Sells
| 1 |
MEI Pharma
MEIP
|
$3.11M |
| 2 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$763K |
| 3 |
Barings BDC
BBDC
|
$302K |
| 4 |
GARS
Garrison Capital Inc.
GARS
|
$49.8K |
| 5 |
Marker Therapeutics
MRKR
|
$28.4K |
Sector Composition
| 1 | Healthcare | 69.88% |
| 2 | Financials | 10.61% |
| 3 | Real Estate | 1.63% |
| 4 | Utilities | 1.11% |
| 5 | Industrials | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRNS
26
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $202K | 0.19% | 20,180 +7,075 | +54% | +$70.8K |
|
27
Credit Acceptance
CACC
$5.78B
| $201K | 0.19% | +459 | New | +$201K |
|
|
SRRA
28
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $190K | 0.18% | 111,898 +78,167 | +232% | +$133K |
|
|
29
Barings BDC
BBDC
$1.04B
| – | – | -26,286 | Closed | -$302K |
|
30
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
|
ONCT
31
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| – | – | -49,805 | Closed | -$763K |
|